INVIVOX

INVIVOX Competitive Intelligence & Landscape

invivox.com ·

INVIVOX
ForesightIQ Predictions

What is INVIVOX likely to do next?

ForesightIQ connects INVIVOX's hiring, product, web, ad, and market signals to forecast strategic moves — often months before they're announced.

Hiring signal

Senior hiring patterns point to a planned enterprise product line launching within two quarters.

High confidence · Next 1–2 quarters
Product signal

Quiet changes to docs and pricing pages signal an upcoming usage-based pricing tier and new API surface.

Likely · Next quarter
Market signal

Ad spend and partnership activity indicate a push into the mid-market segment across two new regions.

Plausible · Next 2–3 quarters
INVIVOX Unlock INVIVOX's predicted moves

Free · generated in ~60 seconds · no signup to preview

Overview

INVIVOX Overview

INVIVOX (invivox.com) is a leading medical training platform dedicated to enhancing healthcare professionals' knowledge and practice through peer-to-peer content sharing. The company, co-founded by Julien Delpech (CEO) and Patxi Ospital (Managing Director), provides a vast library of short, practical, and interdisciplinary content, with 95% of its offerings being free. Its mission, as articulated by CEO Julien Delpech, emphasizes the creation and dissemination of content to health professionals, particularly vital during new health crises. The platform serves as a strategic asset for laboratories and institutions to engage medical professionals sustainably.

INVIVOX targets a broad spectrum of healthcare professionals, including General Practitioners, Nurses, Midwives, Pharmacists, Medical Interns, Physiotherapists, and specialists in fields such as Cardiology, Gynecology, Emergency Medicine, and Geriatrics. The platform boasts over 680,000 healthcare professional registrations, more than 2,000 available content pieces, and partnerships with 160 institutions. Content formats are varied, including short videos, webinars, quizzes, and real-world case studies, all designed to be highly impactful and accessible on demand for busy professionals. The average content rating stands at an impressive 4.5 out of 5.

Beyond individual learning, INVIVOX collaborates with health industry partners, training organizations, learned societies, and university hospitals through initiatives like Invivox Academy. These partnerships, exemplified by a significant agreement with Philips for medical training, focus on improving the education of healthcare professionals, addressing industry challenges and trends, navigating medical regulations, mastering digital communication channels, and fostering digital innovations for patients.

INVIVOX operates under the legal entity In Situ Training – SA, with its headquarters in Bordeaux, France.

Competitors

INVIVOX Competitors

Invivox (invivox.com) stands out in the medical training sector as a leader in knowledge sharing among peers, providing an extensive platform for healthcare professionals. The company, founded in 2016 in Pessac, France, by Richard Rohou, Nicolas Reffait, Julien Delpech, and Patxi Ospital, focuses on democratizing and facilitating access to healthcare knowledge to enhance patient care globally. They offer a vast library of over 2,000 short, practical, and interdisciplinary content pieces, with 95% of their content available for free. With over 680,000 healthcare professional registrations and partnerships with 160 institutions, Invivox has established itself as a go-to resource for accessible and relevant medical education.

Among Invivox's key competitors in the medical education technology space is AMBOSS. AMBOSS differentiates itself as a comprehensive medical learning platform that offers a vast medical knowledge library, an integrated Qbank for exam preparation, and clinical decision support tools. While Invivox focuses on peer-to-peer knowledge sharing and practical, short-form content, AMBOSS provides a more structured and extensive learning experience often geared towards medical students and residents preparing for licensing exams. In terms of market share, AMBOSS has a significant presence, especially in the academic medical community, potentially surpassing Invivox in areas requiring in-depth, exam-oriented study. Pricing models likely differ, with AMBOSS typically offering subscription-based access to its premium features, whereas Invivox emphasizes its high percentage of free content.

Another significant competitor is Osmosis, which positions itself as a visual-first learning platform for medical and health education. Osmosis excels in using engaging videos, flashcards, and practice questions to simplify complex medical topics. While Invivox provides diverse content types for daily practice and ongoing professional development, Osmosis's strength lies in its highly visual and mnemonic-based approach, which can be particularly effective for foundational learning and retention. Both platforms aim to support healthcare professionals, but Osmosis often targets a broader audience from students to practitioners, with a strong emphasis on explaining core concepts, potentially giving it a broader market reach in foundational medical education compared to Invivox's focus on practical application and peer expertise.

Picmonic also competes in the medical education market, distinguishing itself with unique, memorable visual and mnemonic learning tools. Picmonic transforms difficult-to-remember facts into engaging story-based images, aiding in long-term retention. In contrast to Invivox's focus on current practical knowledge shared by experts and its diverse course formats, Picmonic is more specialized in making specific, detailed medical facts easier to recall, particularly valuable for rote memorization required in various medical exams. Its niche market positioning focuses on memory aids, offering a different value proposition than Invivox's broader interdisciplinary and practical content. While Invivox boasts a large library of free content, Picmonic typically operates on a premium subscription model for its specialized resources.

Beyond direct e-learning platforms, mycme stands as a competitor, focusing specifically on Continuing Medical Education (CME) and professional development. Mycme often provides accredited courses, which are crucial for healthcare professionals needing to fulfill licensure requirements. While Invivox offers a wide array of practical content for ongoing learning, mycme's differentiator is its emphasis on formal accreditation and structured CME pathways. This can make mycme a preferred choice for professionals whose primary goal is to accumulate CME credits, a feature that, while potentially present on Invivox, is a core offering and market positioning for mycme. Pricing for mycme's accredited courses is often based on individual course purchases or institutional subscriptions, differing from Invivox's model which largely features free content for general professional enhancement.

Alternatives

INVIVOX Alternatives

Product & Pricing

INVIVOX Product and Pricing Intelligence

Invivox (invivox.com) operates as a leading platform dedicated to medical training and knowledge sharing among healthcare professionals. The company focuses on empowering care, breaking barriers, and facilitating access to relevant healthcare knowledge. Its primary offering is a vast library of short, practical, and interdisciplinary content designed to fit into busy professional schedules, ensuring continuous learning and improved patient care [invivox.com/en/about].

The pricing model for Invivox largely centers around content accessibility. A significant portion of the content, specifically 95%, is available for free to healthcare professionals [invivox.com]. This free access includes a wide array of e-learning courses, replays of webinars, and practical guides covering various medical specialties such as general medicine, cardiology, emergency medicine, and more [invivox.com]. These free offerings often come with quizzes and video explanations to reinforce clinical practice.

While the majority of content is free for individual healthcare professionals, the platform also features content where the Price for access is set exclusively by the Provider (e.g., laboratories offering training) [invivox.com/assets/pdf/INVIVOX_CGU_EN.pdf]. For healthcare industries, training organizations, learned societies, or university hospitals, Invivox provides a platform to engage healthcare professionals durably. This includes transforming contacts into lasting relationships, content into experiences, and campaigns into strategic assets [invivox.com/en/business]. Although specific tiered pricing for these business solutions is not publicly detailed, the company emphasizes creating digital innovations and mastering digital communication channels for its partners, suggesting a tailored service model for institutional clients through Invivox Academy [invivox.com/en/department/profile/invivox-academy].

Hiring & Layoffs

INVIVOX Hiring and Layoffs

While specific details regarding recent hiring trends or layoffs for INVIVOX (invivox.com) are not explicitly available from the provided sources, the company's core mission and growth indicate a potential for ongoing recruitment, particularly in areas supporting their digital medical education platform.

INVIVOX operates as a leader in peer-to-peer knowledge sharing for healthcare professionals, offering a vast library of free content, which suggests a need for specialists in content creation, platform development, and partnership management.

The company's focus on expanding its content offerings and engaging a large community of healthcare professionals (over 680,000 registrations and 2,000+ available contents) points to a strategy centered on growth and user acquisition [invivox.com/]. This likely translates into a demand for roles in areas such as digital marketing, content curation, educational program development, and customer support for their professional users. Their emphasis on transforming contacts into lasting relationships and campaigns into strategic assets for laboratories further indicates a need for business development and sales professionals [invivox.com/en/business].

Given that INVIVOX aims to empower care and break barriers in healthcare knowledge sharing, their hiring patterns would likely reflect a commitment to innovation and accessibility in medical training [invivox.com/en/about]. Roles that contribute to developing user-friendly interfaces, enhancing content relevance, and expanding their network of contributors would be crucial. The absence of layoff information suggests a stable operational environment, with a consistent drive to enhance their platform and maintain their position as a go-to resource for healthcare professionals seeking practical, interdisciplinary content.

Leadership

INVIVOX Management and Leadership Team

INVIVOX (invivox.com) is spearheaded by its co-founders, Julien Delpech and Patxi Ospital. Julien Delpech serves as the CEO of Invivox, and notably contributed to a mission focused on "Creation & Dissemination of content to health professionals in the event of a new health crisis" at the French Ministry of Solidarity and Health. Patxi Ospital holds the position of Managing Director at Invivox, playing a crucial role in the company's operational and strategic direction [invivox.com/en/board]. Their combined leadership has established Invivox as a leader in medical training and knowledge sharing among healthcare professionals [invivox.com/en].

The INVIVOX Board of Directors includes additional key members such as Marie Geneste and Chahra Louafi, who contribute to the strategic governance and oversight of the company [invivox.com/en/board]. The company's commitment to facilitating access to medical education is further underscored by its collaborations, such as the partnership with Institut Curie to enhance oncology education for physicians globally [blog.invivox.com/post/institut-curie-and-invivox-join-forces-to-facilitate-access-to-oncology-education-for-physicians-around-the-world/].

In a significant development, INVIVOX joined the Microsoft for Startups program, which is expected to reinforce its ambition in knowledge sharing among healthcare professionals and accelerate its global footprint [blog.invivox.com/post/communique-presse-microsoft-for-startups/]. This collaboration highlights INVIVOX's forward-thinking approach to leveraging technology to empower healthcare professionals with accessible and relevant knowledge [invivox.com/en/about].

Financials

INVIVOX Financial Performance, Fundraising, M&A

INVIVOX (invivox.com) is a prominent leader in medical knowledge sharing, offering a platform that transforms interactions into lasting relationships and content into valuable experiences for healthcare professionals and laboratories alike. The company boasts significant engagement with over 680,000 healthcare professional registrations and provides access to more than 2,000 available content pieces. With 95% of its content being free, INVIVOX maintains a strong average content rating of 4.5, collaborating with 160 institutional partners to deliver high-quality, interdisciplinary content. The company, operating as In Situ Training (IST), is a French “société anonyme” with a capital of 288,014 Euros, demonstrating a solid financial foundation for its operations.

From a fundraising perspective, INVIVOX secured a direct Series A investment from BPI (Banque Publique d'Investissement) France and the ISAI investment fund after its launch in 2015 [blog.invivox.com/post/philips-and-invivox-seal-their-medical-training-partnership-for-healthcare-professionals/]. This initial funding was crucial in positioning INVIVOX to contribute to France's role as a strategic international hub for medical training, with plans for European deployment by 2020. Further demonstrating its growth and strategic partnerships, INVIVOX joined the Microsoft for Startups program, which is expected to accelerate its global footprint and increase its reach within the healthcare knowledge-sharing sector [blog.invivox.com/post/communique-presse-microsoft-for-startups/].

While specific revenue figures are not publicly disclosed, the substantial number of professional registrations and available content pieces indicate a thriving platform.

INVIVOX's focus on engaging healthcare professionals through valuable, on-demand content suggests a robust business model aimed at sustainable growth. The involvement of impact investment funds like Educapital, founded in 2017 and dedicated to the future of education and work, further underscores confidence in INVIVOX's potential for expansion and impact in the Edtech sector [invivox.com/en/board].

Partnerships

INVIVOX Partnerships, Clients and Vendors

INVIVOX (invivox.com) has established a robust network of partnerships, clients, and technological integrations, solidifying its position as a leader in medical knowledge sharing. The company actively collaborates with significant institutions and industry giants to enhance and expand its offerings. Notably, INVIVOX has partnered with Philips to provide medical training for healthcare professionals, a strategic agreement that includes clinical training on equipment and solutions, as well as Masterclasses on digital health technologies [blog.invivox.com/post/philips-and-invivox-seal-their-medical-training-partnership-for-healthcare-professionals/]. This collaboration highlights INVIVOX's growing presence among medical device manufacturers and industrial partners [blog.invivox.com/post/philips-et-invivox-officialisent-leur-partenariat-pour-la-formation-medicale-des-professionnels-de-sante].

Beyond industry collaborations, INVIVOX has forged key alliances with prestigious medical and research institutions. The Institut Curie, renowned globally for cancer research and treatment, joined forces with INVIVOX to facilitate access to oncology education for physicians worldwide [blog.invivox.com/post/institut-curie-and-invivox-join-forces-to-facilitate-access-to-oncology-education-for-physicians-around-the-world/]. Similarly, the Académie Nationale de Chirurgie and INVIVOX signed a partnership charter to leverage digital savoir-faire for disseminating French surgical expertise [blog.invivox.com/post/annonce-partenariat-invivox-academie-nationale-de-chirurgie/]. Another significant partnership is with IRCAD France, an international institute for surgical training, which utilizes INVIVOX to increase the global visibility of its continuing education courses for surgeons [blog.invivox.com/post/invivox-and-ircad-france-join-forces/].

INVIVOX also demonstrates strong engagement with technology and enterprise clients. The company joined the Microsoft for Startups program, a move that reinforces its ambition in knowledge sharing among healthcare professionals and is expected to accelerate its footprint and growth [blog.invivox.com/post/communique-presse-microsoft-for-startups/]. In terms of specific clients, SkinCeuticals utilizes the INVIVOX platform to engage healthcare professionals, offering an integrated skincare approach that combines powerful products with clinical procedures [invivox.com/en/department/profile/skinceuticals]. This diverse range of partnerships and client relationships underscores INVIVOX's commitment to transforming healthcare professional engagement through accessible, high-quality content and strategic alliances [invivox.com/en/business].

Events

INVIVOX Event Participations

INVIVOX (invivox.com) actively facilitates a wide array of educational events for healthcare professionals, serving as a leading platform for medical training and knowledge sharing among peers. The platform hosts numerous online events, including webinars, courses, and replays, often featuring content developed in partnership with institutions and medical companies. These events cover diverse specialties such as general medicine, cardiology, pulmonology, urology, and more, providing practical and interdisciplinary content to support daily medical practice [invivox.com].

The company frequently hosts digital events and webinars that attract a large audience of healthcare professionals. Examples include "The power of triple single-pill combinations in addressing a qualitative BP control" by Servier and Omron, and "Dyslipidemia & CV Risk: From Primary Prevention to Effective Outcomes" also by Servier, both designed for thousands of participants [invivox.com/en/training/detail/SERV96295][invivox.com/en/training/detail/SERV76984]. Other notable online events include "International networking opportunities in Healthcare support and Development for surgeons" and various sessions on respiratory care like "Lung Volume Reduction under the roof of interdisciplinarity" and "Current Strategies to Deliver Effective Non-Invasive Ventilation" [invivox.com/en/training/detail/BSUR80433][invivox.com/en/training/detail/PULX92710][invivox.com/en/training/detail/VYAI49982]. These events often offer CME credits and are available for replay, ensuring broad accessibility for busy professionals.

Beyond digital formats, INVIVOX also supports hybrid and in-person events, demonstrating its versatility in medical education delivery [invivox.com/en/department/profile/invivox-academy]. For instance, a "Clinical Immersion" event by BCI Academy offered a one-day operating room immersion in Bordeaux, France, providing hands-on experience for a limited number of participants [invivox.com/en/training/detail/BCIA43198?origin=search+-+recents]. The platform aims to redefine and manage various types of events, fostering a comprehensive ecosystem for continuous professional development within the healthcare sector [invivox.com/en/department/profile/invivox-academy].

Frequently Asked Questions

What is INVIVOX's strategic intent behind offering 95% of its medical content for free?

INVIVOX's strategy of offering 95% free content aims to maximize accessibility for healthcare professionals, fostering a large user base of over 680,000 registrations. This approach establishes INVIVOX as a go-to resource for continuous medical education, creating a robust ecosystem for knowledge sharing that then attracts institutional and industry partners seeking to engage this professional audience through tailored solutions and paid content.

What do INVIVOX's recent partnerships, particularly with Philips and Microsoft for Startups, signal about its strategic direction?

INVIVOX's partnerships with Philips and Microsoft for Startups signal a strategic dual focus: strengthening its ties with major medical device manufacturers for content co-creation and expanding its global technological footprint. The Philips collaboration indicates a drive to integrate training on advanced medical equipment and digital health, while the Microsoft partnership is geared towards accelerating global reach and leveraging cutting-edge technology for its platform.

How does INVIVOX's event strategy, encompassing online, hybrid, and in-person formats, position it in the medical education market?

INVIVOX's versatile event strategy, which includes extensive online webinars, courses, and replays alongside select hybrid and in-person events like surgical immersions, positions it as a comprehensive and adaptable medical education provider. This multi-format approach maximizes accessibility and engagement for a diverse range of healthcare professionals, from those seeking flexible digital learning to those requiring hands-on experience, supporting a broad spectrum of continuous professional development needs.

What does the high volume of 'free content' and 'professional registrations' on INVIVOX imply about its business model, given limited public financial disclosures?

The high volume of free content (95%) and over 680,000 professional registrations on INVIVOX, despite limited public revenue figures, implies a business model centered on audience aggregation and value creation for institutional partners. The company likely monetizes its platform by offering laboratories, training organizations, and university hospitals a strategic asset for sustainable engagement with a large, qualified healthcare professional audience through tailored solutions and potentially provider-set pricing for specialized content or campaigns.

What do INVIVOX's co-founders' roles, Julien Delpech (CEO) and Patxi Ospital (Managing Director), suggest about the company's operational focus?

The co-founder structure with Julien Delpech as CEO and Patxi Ospital as Managing Director suggests a balanced operational focus for INVIVOX. Delpech's involvement with the French Ministry of Solidarity and Health on content dissemination indicates a strategic emphasis on public health impact and broad knowledge sharing, while Ospital's Managing Director role points to a strong focus on the day-to-day operational execution and strategic growth of the platform.

How does INVIVOX differentiate its offering from competitors like AMBOSS and Osmosis, based on its content strategy?

INVIVOX differentiates from AMBOSS and Osmosis through its primary focus on peer-to-peer knowledge sharing and short, practical, interdisciplinary content, with 95% offered free. While AMBOSS focuses on comprehensive, exam-oriented medical knowledge and Osmosis on visual, mnemonic-based foundational learning, INVIVOX emphasizes accessible, on-demand content for daily practice and ongoing professional development, leveraging a network of expert contributions.

What is the significance of INVIVOX's partnership with Institut Curie in terms of its content strategy and market positioning?

INVIVOX's partnership with Institut Curie is significant as it enhances its content strategy by adding specialized, high-demand oncology education from a globally renowned institution. This collaboration elevates INVIVOX's market positioning by demonstrating its ability to partner with leading research bodies, facilitating access to critical, expert-led medical training for physicians worldwide and reinforcing its credibility in diverse medical specialties.

Does INVIVOX's strong emphasis on free content for healthcare professionals impact its competitive standing against CME-focused platforms like mycme?

INVIVOX's strong emphasis on 95% free content likely positions it differently from CME-focused platforms like mycme. While mycme specializes in accredited courses crucial for licensure requirements, INVIVOX offers a broader array of practical content for general professional enhancement. This allows INVIVOX to attract a wider audience seeking continuous, informal learning, potentially as a complementary resource rather than a direct substitute for formal CME credit accumulation.

What does the capital structure of In Situ Training – SA with 288,014 Euros indicate about INVIVOX's financial health or growth stage?

The capital of In Situ Training – SA at 288,014 Euros indicates a solid foundational financial structure for INVIVOX, a French "société anonyme." This figure, combined with Series A investment from BPI France and ISAI, suggests the company is well-capitalized for its operational needs and strategic growth, aiming for European deployment and global expansion rather than being a nascent startup still seeking initial seed funding.

Given INVIVOX's focus on a large number of 'available content pieces' and 'professional registrations,' what are the likely challenges for maintaining content quality and relevance?

Maintaining content quality and relevance for INVIVOX's over 2,000 available content pieces and 680,000+ professional registrations likely presents challenges related to curation, validation, and continuous updating. With 95% free content and a peer-to-peer model, the company must ensure that its diverse, interdisciplinary offerings consistently meet a high standard, are evidence-based, and remain current with evolving medical practices, potentially requiring significant content management resources.

What does the inclusion of impact investment funds like Educapital in INVIVOX's board suggest about its long-term vision?

The inclusion of impact investment funds like Educapital, dedicated to the future of education and work, on INVIVOX's board suggests a long-term vision centered on sustainable growth and significant societal impact within the Edtech sector. This indicates INVIVOX is not solely focused on short-term profitability but also on its role in transforming medical education and empowering healthcare professionals globally, aligning with Educapital's mission.

Powered by ForesightIQ · Competitive intelligence from digital exhaust